Changes in the blood coagulation system in patients with chronic heart failure
Open Access
- 31 May 2023
- journal article
- research article
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 101 (4-5) , 181-187
Abstract
The article provides a review of scientifi c publications dedicated to the study of the hemostatic system in patients with chronic heart failure (CHF). Russian and foreign authors evaluated the risks of bleeding and thrombosis in patients with CHF, as well as changes in the content of individual markers and factors of the coagulation system. The review suggests that the results obtained are quite contradictory. On the one hand, data is presented on an increased risk of thrombosis, changes in the content of some endothelial markers that promote endothelial thrombogenicity, an increase in the content of platelet aggregation markers, and elevated levels of fi brinogen and thrombin. On the other hand, there is data on an increased risk of bleeding in patients with CHF, an increase in some endothelial markers that enhance the anticoagulant properties of the endothelium. From the analysis conducted, it can be concluded that this topic is not suffi ciently studied, and it is diffi cult to judge the hemostatic potential in patients with CHF at present. The use of integrated methods such as thromboelastography (TEG) and low-frequency piezothromboelastography (LF-PTEG) are a promising direction for studying this problem. The results obtained using these methods will likely allow for a more precise understanding of the features of the coagulation system functioning in patients with CHF.Keywords
This publication has 36 references indexed in Scilit:
- Symptoms and clinical relevance: A dilemma for clinical trials on prevention of venous thromboembolismThrombosis and Haemostasis, 2013
- Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patientsInternational Journal of Cardiology, 2008
- Inflammatory markers in stable heart failure and their relationship with functional classInternational Journal of Cardiology, 2008
- Citrate anticoagulation and the dynamics of thrombin generationJournal of Thrombosis and Haemostasis, 2007
- Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: The Frederiksberg heart failure studyInternational Journal of Cardiology, 2006
- Endothelial Activation, Dysfunction, and Damage in Congestive Heart Failure and the Relation to Brain Natriuretic Peptide and OutcomesThe American Journal of Cardiology, 2006
- Soluble CD40 ligand in acute and chronic heart failureEuropean Heart Journal, 2005
- Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantationBritish Journal of Haematology, 2004
- Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for β-blocker selectionClinical Science, 2003
- Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside.Circulation, 1979